MTOR and neoplasm: Until recently, several inhibitors targeting mTOR had been studied for their efficacy in tumor therapy; among these, Torin 1 and Torin 2 are new generation mTOR inhibitors demonstrated to be effective in several cancer types [49,50,51,52,53,54].